Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
J Neurol ; 263(8): 1575-82, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27230856

ABSTRACT

α-Synucleinopathies, such as Parkinson's disease (PD) and dementia with Lewy bodies (DLB), are characterized by α-synuclein accumulation from brainstem structures to the neocortex. PD and DLB are clinically distinguishable, while discrimination between Parkinson Disease Dementia (PDD) and DLB can be subtle and based on the temporal relationship between motor and cognitive symptoms. To explore patterns of subcortical atrophy in PD, PDD and DLB, and assess specific differences between PD and PDD, and between DLB and PDD. 16 PD, 11 PDD and 16 DLB patients were recruited and underwent 1.5 Tesla structural MRI scanning. Segmentation of subcortical structures was performed with a well-validated, fully-automated tool, and volume and shape for each structure were compared between groups. PDD and DLB patients showed global subcortical atrophy compared to PD patients. Greater hippocampal atrophy was the specific trait that distinguished PDD from PD, while greater atrophy of the pallidi discriminated DLB from PDD. Vertex analysis revealed specific shape differences in both structures. Our results suggest that automated, time-sparing, subcortical volumetry may provide diagnostically useful information in α-synucleinopathies. Future studies on larger samples and with iron-sensitive MRI contrasts are needed.


Subject(s)
Brain/diagnostic imaging , Dementia/diagnostic imaging , Lewy Body Disease/diagnostic imaging , Magnetic Resonance Imaging , Parkinson Disease/diagnostic imaging , alpha-Synuclein/metabolism , Analysis of Variance , Chi-Square Distribution , Female , Humans , Image Processing, Computer-Assisted , Italy , Male , Neuropsychological Tests , Pilot Projects , Psychiatric Status Rating Scales , Severity of Illness Index
2.
Eur J Neurol ; 22(9): 1317-22, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26073740

ABSTRACT

BACKGROUND AND PURPOSE: Corticobasal syndrome (CBS) is a clinical entity characterized by higher cortical dysfunctions associated with asymmetric onset of levodopa-resistant parkinsonism, dystonia and myoclonus. One of the most typical and distressful features of CBS is limb apraxia, which affects patients in their everyday life. Transcranial direct current stimulation (tDCS) is a non-invasive procedure of cortical stimulation, which represents a promising tool for cognitive enhancement and neurorehabilitation. The present study investigated whether anodal tDCS over the parietal cortex (PARC), would improve ideomotor upper limb apraxia in CBS patients. METHODS: Fourteen patients with possible CBS and upper limb apraxia were enrolled. Each patient underwent two sessions of anodal tDCS (left and right PARC) and one session of placebo tDCS. Ideomotor upper limb apraxia was assessed using the De Renzi ideomotor apraxia test that is performed only on imitation. RESULTS: A significant improvement of the De Renzi ideomotor apraxia test scores (post-stimulation versus pre-stimulation) after active anodal stimulation over the left PARC was observed (χ(2) = 17.6, P = 0.0005), whilst no significant effect was noticed after active anodal stimulation over the right PARC (χ(2) = 7.2, P = 0.07). A post hoc analysis revealed a selective improvement in the De Renzi ideomotor apraxia score after active anodal stimulation over the left PARC compared with placebo stimulation considering both right (P = 0.03) and left upper limbs (P = 0.01). CONCLUSIONS: These findings indicate that tDCS to the PARC improves the performance of an ideomotor apraxia test in CBS patients and might represent a promising tool for future rehabilitation approaches.


Subject(s)
Apraxia, Ideomotor/therapy , Arm/physiopathology , Gestures , Neurodegenerative Diseases/rehabilitation , Parietal Lobe/physiopathology , Transcranial Direct Current Stimulation/methods , Aged , Apraxia, Ideomotor/etiology , Basal Ganglia Diseases/complications , Basal Ganglia Diseases/rehabilitation , Female , Humans , Male , Middle Aged , Neurodegenerative Diseases/complications , Syndrome , Treatment Outcome
3.
Hum Exp Toxicol ; 31(5): 421-37, 2012 May.
Article in English | MEDLINE | ID: mdl-21729976

ABSTRACT

Cobalt exerts well-known and documented toxic effects on the thyroid, heart and the haematopoietic system, in addition to the occupational lung disease, allergic manifestations and a probably carcinogenic action. Cobalt neurotoxicity is reported in isolated cases, and it has never been systematically treated. Bilateral optic atrophy and retinopathy, bilateral nerve deafness and sensory-motor polyneuropathy have been described long ago as a result of chronic occupational exposure to cobal powder or during long-term treatment of anaemia with cobalt chloride. Recently, some patients with high levels of cobalt released from metal prosthesis have been referred as presenting with tinnitus, deafness, vertigo, visual changes, optic atrophy, tremor and peripheral neuropathy. The aim of this work is to group these cases and to identify a possible mechanism of cobalt neurotoxicity, focusing on hypothetic individual susceptibility such as altered metal-binding proteins, altered transport processes in target cells or polymorphic variation of genetic background.


Subject(s)
Cobalt/toxicity , Neurotoxicity Syndromes/etiology , Cobalt/pharmacokinetics , Humans , Occupational Exposure/adverse effects , Prostheses and Implants/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL